AMPA receptor potentiators as novel antidepressants.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Current pharmaceutical design

• Publication date

  2005-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1381612053764814PMID 15892659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Possibility of non-immunosuppressive immunophilin ligands as potential therapeutic agents for Parkinson's disease.

  2004cited by this paper
• Is the forced swimming test a suitable model for revealing antidepressant activity?

  2004cited by this paper
• PET imaging of beta-adrenoceptors in human brain: a realistic goal or a mirage?

  2004cited by this paper
• Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain.

  2003cited by this paper
• Enhancement of Antidepressant Potency by a Potentiator of AMPA Receptors

  2003cited by this paper
• Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants

  2003cited by this paper
• Bi-phasic change in BDNF gene expression following antidepressant drug treatment.

  2003cited by this paper
• AMPA Receptor Stimulation within the Central Nucleus of the Amygdala Elicits a Differential Activation of Central Dopaminergic Systems

  2003cited by this paper
• Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.

  2003cited by this paper
• Chronic AMPA receptor potentiator (LY451646) treatment increases cell proliferation in adult rat hippocampus.

  2003cited by this paper
• Animal models of depression: are there any?

  2003cited by this paper
• ECT of Major Depressed Patients in Relation to Biological and Clinical Variables: A Brief Overview

  2003cited by this paper
• PACAP in avians: origin, occurrence, and receptors--pharmacological and functional considerations.

  2003cited by this paper
• LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.

  2003cited by this paper
• Activation of the TrkB Neurotrophin Receptor Is Induced by Antidepressant Drugs and Is Required for Antidepressant-Induced Behavioral Effects

  2003cited by this paper
• Multiple Molecular Determinants for Allosteric Modulation of Alternatively Spliced AMPA Receptors

  2003cited by this paper
• Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model.

  2002cited by this paper
• Assessing antidepressant activity in rodents: recent developments and future needs.

  2002cited by this paper
• Neurobiology of depression.

  2002cited by this paper
• An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study.

  2002cited by this paper
• Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study.

  2002cited by this paper
• cAMP Response Element-Binding Protein Is Essential for the Upregulation of Brain-Derived Neurotrophic Factor Transcription, But Not the Behavioral or Endocrine Responses to Antidepressant Drugs

  2002cited by this paper
• Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac)

  2002cited by this paper
• Volumetric MRI studies of mood disorders: do they distinguish unipolar and bipolar disorder?

  2002cited by this paper
• Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus.

  2002cited by this paper
• Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression

  2002cited by this paper
• Volumetric brain imaging findings in mood disorders.

  2002cited by this paper
• Antidepressants and neuroplasticity.

  2002cited by this paper
• The cellular neurobiology of depression

  2001cited by this paper
• Infusion of Brain-Derived Neurotrophic Factor into the Lateral Ventricle of the Adult Rat Leads to New Neurons in the Parenchyma of the Striatum, Septum, Thalamus, and Hypothalamus

  2001cited by this paper
• Mammalian MAP kinase signalling cascades

  2001cited by this paper
• Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder.

  2001cited by this paper
• The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory

  2001cited by this paper
• Current perspectives on the development of non-biogenic amine-based antidepressants.

  2001cited by this paper
• Molecular physiology of kainate receptors.

  2001cited by this paper
• Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator.

  2001cited by this paper
• Regulation of Adult Neurogenesis by Antidepressant Treatment

  2001cited by this paper
• Glia: listening and talking to the synapse

  2001cited by this paper
• Pharmacotherapy of mental illness--a historical analysis.

  2001cited by this paper
• Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder.

  2001cited by this paper
• Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro.

  2001cited by this paper
• The Economics of Selective Serotonin Reuptake Inhibitors In Depression

  2001cited by this paper
• Antidepressant-like actions of an AMPA receptor potentiator (LY392098).

  2001cited by this paper
• Control of synapse number by glia.

  2001cited by this paper
• Intra- and interstrain differences in models of "behavioral despair".

  2001cited by this paper
• Enhanced axonal growth from fetal human bcl-2 transgenic mouse dopamine neurons transplanted to the adult rat striatum.

  2001cited by this paper
• Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders.

  2001cited by this paper
• Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors in vitro.

  2001cited by this paper
• Reduction of Submissive Behavior in Rats: A Test for Antidepressant Drug Activity

  2001cited by this paper
• Neurotrophins as synaptic modulators

  2001cited by this paper
• Administration of a cAMP Phosphodiesterase 4 Inhibitor Enhances Antidepressant-Induction of BDNF mRNA in Rat Hippocampus

  2000cited by this paper
• Biarylpropylsulfonamides as novel, potent potentiators of 2-amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)- propanoic acid (AMPA) receptors.

  2000cited by this paper
• Coactivation of beta-adrenergic and cholinergic receptors enhances the induction of long-term potentiation and synergistically activates mitogen-activated protein kinase in the hippocampal CA1 region.

  2000cited by this paper
• Positive Modulation of AMPA Receptors Increases Neurotrophin Expression by Hippocampal and Cortical Neurons

  2000cited by this paper
• Regulation of Phosphorylation of the GluR1 AMPA Receptor in the Neostriatum by Dopamine and Psychostimulants In Vivo

  2000cited by this paper
• CREB couples neurotrophin signals to survival messages.

  2000cited by this paper
• Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells.

  2000cited by this paper
• Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity

  2000cited by this paper
• Increased neurogenesis in a model of electroconvulsive therapy.

  2000cited by this paper
• Enhancement of Hippocampal Neurogenesis by Lithium

  2000cited by this paper
• Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus

  2000cited by this paper
• Transcriptional and post‐transcriptional regulation of a brain growth protein: regional differentiation and regeneration induction of GAP‐43

  2000cited by this paper
• Transgenic mice overexpressing truncated trkB neurotrophin receptors in neurons show increased susceptibility to cortical injury after focal cerebral ischemia.

  2000cited by this paper
• Mind glue: implications of glial cell biology for psychiatry.

  2000cited by this paper
• Stress and hippocampal plasticity.

  1999cited by this paper
• Mechanism of action of antidepressant medications.

  1999cited by this paper
• Protein phosphatase 1 modulation of neostriatal AMPA channels: regulation by DARPP–32 and spinophilin

  1999cited by this paper
• Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures.

  1999cited by this paper
• Optic Nerve Crush: Axonal Responses in Wild-Type and bcl-2 Transgenic Mice

  1999cited by this paper
• Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms.

  1999cited by this paper
• Antidepressants for the new millennium.

  1999cited by this paper
• A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression.

  1999cited by this paper
• Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons

  1999cited by this paper
• The Mitogen-Activated Protein Kinase Cascade Couples PKA and PKC to cAMP Response Element Binding Protein Phosphorylation in Area CA1 of Hippocampus

  1999cited by this paper
• Repeated stress increases catalytic TrkB mRNA in rat hippocampus.

  1999cited by this paper
• The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn

  1999cited by this paper
• The glutamate receptor ion channels.

  1999cited by this paper
• Why do mature CNS neurons of mammals fail to re-establish connections following injury–functions of Bcl-2

  1998cited by this paper
• Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb.

  1998cited by this paper
• Neuropharmacology of AMPA and kainate receptors.

  1998cited by this paper
• Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress.

  1998cited by this paper
• Novel therapeutic approaches beyond the serotonin receptor.

  1998cited by this paper
• Neurogenesis in the Dentate Gyrus of the Adult Tree Shrew Is Regulated by Psychosocial Stress and NMDA Receptor Activation

  1997cited by this paper
• The adult rat hippocampus contains primordial neural stem cells.

  1997cited by this paper
• A molecular and cellular theory of depression.

  1997cited by this paper
• A Novel Allosteric Potentiator of AMPA Receptors: 4-[2-(Phenylsulfonylamino)ethylthio]-2,6-Difluoro-Phenoxyacetamide

  1997cited by this paper
• Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline

  1997cited by this paper
• Anterograde transport of endogenous brain‐derived neurotrophic factor in hippocampal mossy fibers

  1997cited by this paper
• Subunit Composition, Kinetic, and Permeation Properties of AMPA Receptors in Single Neocortical Nonpyramidal Cells

  1997cited by this paper
• Dentate Granule Cell Neurogenesis Is Increased by Seizures and Contributes to Aberrant Network Reorganization in the Adult Rat Hippocampus

  1997cited by this paper
• Bcl-2 promotes regeneration of severed axons in mammalian CNS

  1997cited by this paper
• GAP-43: an intrinsic determinant of neuronal development and plasticity.

  1997cited by this paper
• Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).

  1997cited by this paper
• Targeting of the CREB gene leads to up‐regulation of a novel CREB mRNA isoform.

  1996cited by this paper
• AMPA Receptor Flip/Flop Mutants Affecting Deactivation, Desensitization, and Modulation by Cyclothiazide, Aniracetam, and Thiocyanate

  1996cited by this paper
• CREB phosphorylation and dephosphorylation: a Ca(2+)- and stimulus duration-dependent switch for hippocampal gene expression.

  1996cited by this paper
• Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain.

  1996cited by this paper
• Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation

  1996cited by this paper
• Dentate granule cell layer collagen explant cultures: spontaneous axonal growth and induction by brain-derived neurotrophic factor or basic fibroblast growth factor.

  1996cited by this paper
• Coupling of the RAS-MAPK Pathway to Gene Activation by RSK2, a Growth Factor-Regulated CREB Kinase

  1996cited by this paper

• Preclinical Pharmacology of CX1837, a High-Impact Ampakine with an Improved Safety Margin: Implications for Treating Alzheimer's Disease and Ischemic Stroke.

  2025cites this paper
• All roads lead to glutamate: NMDA and AMPA receptors as targets for rapid-acting antidepressants.

  2025cites this paper
• Global hotspots and trends in AMPA receptor research (2000–2025): a bibliometric and visualization analysis

  2025cites this paper
• 3,4-Dihydrobenzo[e][1,2,3]oxathiazine 2,2-dioxide analogs act as potential AMPA receptor potentiators with antidepressant activity.

  2023cites this paper
• Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies

  2023cites this paper
• Phenylalanine-Based AMPA Receptor Antagonist as the Anticonvulsant Agent with Neuroprotective Activity—In Vitro and In Vivo Studies

  2022cites this paper
• AMPA Receptor Potentiators as Potential Rapid-Acting Antidepressants

  2021cites this paper
• Activation of BDNF-mediated PKA signaling in the ventral hippocampus by Capsosiphon fulvescens glycoproteins alleviates depressive-like behavior in aged rats

  2020cites this paper
• Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms

  2020cites this paper
• S 47445 counteracts the behavioral manifestations and hippocampal neuroplasticity changes in bulbectomized mice.

  2019cites this paper
• Positive Allosteric Modulation of AMPAR by PF-4778574 Produced Rapid Onset Antidepressant Actions in Mice.

  2018cites this paper
• The reduction in glutamate release is predictive of cognitive and emotional alterations that are corrected by the positive modulator of AMPA receptors S 47445 in perinatal stressed rats

  2018cites this paper
• Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)

  2017cites this paper
• The Role of Phosphodiesterase-2 in Psychiatric and Neurodegenerative Disorders.

  2017cites this paper
• Lentinan produces a robust antidepressant‐like effect via enhancing the prefrontal Dectin‐1/AMPA receptor signaling pathway

  2017cites this paper
• Aryl‐ and heteroaryl‐substituted phenylalanines as AMPA receptor ligands

  2017cites this paper
• Phosphodiesterases: CNS Functions and Diseases

  2017cites this paper
• Pharmacological characterization and binding modes of novel racemic and optically active phenylalanine-based antagonists of AMPA receptors.

  2017cites this paper
• Griflola frondosa (GF) produces significant antidepressant effects involving AMPA receptor activation in mice

  2016cites this paper
• Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling.

  2016cites this paper
• The Prefrontal Dectin-1/AMPA Receptor Signaling Pathway Mediates The Robust and Prolonged Antidepressant Effect of Proteo-β-Glucan from Maitake

  2016cites this paper
• EphB2 in the Medial Prefrontal Cortex Regulates Vulnerability to Stress

  2016cites this paper
• Ketamine and other glutamate receptor modulators for depression in adults

  2015cites this paper
• Investigação do envolvimento de subtipos de adrenoceptores α1 no efeito anti-imobilidade da imipramina no teste de suspensão pela cauda

  2015cites this paper
• The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: central mediators of pathophysiology and antidepressant activity?

  2015cites this paper
• Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice.

  2015cites this paper
• Rapid-onset antidepressant efficacy of glutamatergic system modulators: The neural plasticity hypothesis of depression

  2015cites this paper
• The roles of phosphodiesterase 2 in the central nervous and peripheral systems.

  2014cites this paper
• The Involvement of AMPA Receptor in the Antidepressant-like Effects of the Portulaca Oleracea L. Extract in Mice

  2013cites this paper
• Antidepressant-like Effects of the Gastrodia elata Bl Extract in Mice

  2013cites this paper
• Glutamate-based antidepressants: preclinical psychopharmacology.

  2013cites this paper
• Fluvoxamine increased glutamate release by activating both 5-HT(3) and sigma-1 receptors in prelimbic cortex of chronic restraint stress C57BL/6 mice.

  2012cites this paper
• Cognitive Enhancers (Nootropics). Part 1: Drugs Interacting with Receptors

  2012cites this paper
• Rapid-acting antidepressant strategies: mechanisms of action.

  2012cites this paper
• NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice

  2011cites this paper
• NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice

  2011cites this paper
• Die Bedeutung des glutamatergen Systems für Pathophysiologie und Pharmakotherapie der Depression: präklinische und klinische Daten

  2010cites this paper
• The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test

  2010cites this paper
• Antidepressant treatments-induced modifications of glutamatergic transmission in rat frontal cortex.

  2008cites this paper
• Novel Mechanisms of Drug Treatment in Psychiatry

  2008cites this paper
• One more view of neurotrophin-netrotrasmitter signaling in neurons: BDNF-AMPAR crosstalk

  2008cites this paper
• Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant‐like effect via Y1 receptor

  2007cites this paper
• Calcineurin (protein phosphatase 2B) is involved in the mechanisms of action of antidepressants.

  2007cites this paper
• Tricyclic antidepressants, but not the selective serotonin reuptake inhibitor fluoxetine, bind to the S1S2 domain of AMPA receptors

  2007cites this paper
• Innovations in CNS drug discovery: differentiating strategies to treat depression

  2007cites this paper
• The Anticonvulsants Lamotrigine, Riluzole, and Valproate Differentially Regulate AMPA Receptor Membrane Localization: Relationship to Clinical Effects in Mood Disorders

  2007cites this paper
• A role for AMPA receptors in mood disorders.

  2006influential citation
• [Depression and BDNF].

  2006cites this paper
• New approaches to antidepressant drug discovery: beyond monoamines

  2006cites this paper
• Glutamate as a modulator of embryonic and adult neurogenesis.

  2006cites this paper
• A ubiquitous membrane fusion protein αSNAP: a potential therapeutic target for cancer, diabetes and neurological disorders?

  2006cites this paper
• Lamina‐specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia

  2006cites this paper
• Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy.

  2006cites this paper
• Therapeutic Potential of Positive AMPA Receptor Modulators in the Treatment of Neuropsychiatric Disorders

  2006cites this paper
• Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action.

  2006cites this paper
• The role of the glutamatergic system in the pathophysiology and treatment of mood disorders

  2006cites this paper
• Pharmacological Characterization of cGMP Regulation by the Biarylpropylsulfonamide Class of Positive, Allosteric Modulators of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors

  2006cites this paper
• Approche environnementale et génétique de la sensibilité comportementale et moléculaire à deux psychotropes : la cocaïne et la fluoxétine

  2005cites this paper